{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:38Z","timestamp":1791499298447,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.phrs.2020.105295","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T09:36:08Z","timestamp":1604828168000},"page":"105295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux"],"prefix":"10.1016","volume":"163","author":[{"given":"Yong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2020.105295_bib0005","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/annonc\/mdy185","article-title":"Advances in the systemic treatment of melanoma brain metastases","volume":"29","author":"Glitza Oliva","year":"2018","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105295_bib0010","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","article-title":"Metastasis organotropism: redefining the congenial soil","volume":"49","author":"Gao","year":"2019","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0020","article-title":"Hypoxia-induced HIF1\u03b1 targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis","volume":"30","author":"Loftus","year":"2017","journal-title":"Pigm. Cell Melanoma R."},{"key":"10.1016\/j.phrs.2020.105295_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejro.2019.08.001","article-title":"Two synchronous lung metastases from malignant melanoma: the same patient but different morphological patterns","volume":"6","author":"Borghesi","year":"2019","journal-title":"Eur. J. Radiol. Open"},{"issue":"7","key":"10.1016\/j.phrs.2020.105295_bib0030","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4103\/jcrt.JCRT_332_19","article-title":"Melanoma liver metastases with special imaging features on magnetic resonance imaging after microwave ablations: How to evaluate technical efficacy?","volume":"15","author":"Cao","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.phrs.2020.105295_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbo.2017.08.003","article-title":"Complications of bone metastases from malignant melanoma","volume":"8","author":"Zekri","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"15_suppl","key":"10.1016\/j.phrs.2020.105295_bib0040","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.e21585","article-title":"Bone metastasis to predict treatment response rate and overall survival of patients with metastatic melanoma","volume":"36","author":"Lee","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105295_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cncr.30946","article-title":"Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies","volume":"124","author":"Sloot","year":"2018","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2020.105295_bib0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41582-020-0391-x","article-title":"Management of brain metastases according to molecular subtypes","volume":"16","author":"Soffietti","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105295_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/pcmr.12538","article-title":"Melanoma central nervous system metastases: current approaches, challenges, and opportunities","volume":"29","author":"Cohen","year":"2016","journal-title":"Pigm. Cell Melanoma R."},{"key":"10.1016\/j.phrs.2020.105295_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: from bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2020.105295_bib0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2018.00500","article-title":"Drug repositioning for effective prostate cancer treatment","volume":"9","author":"Turanli","year":"2018","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2020.105295_bib0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","article-title":"Cancer risk among users of neuroleptic medication: a population-based cohort study","volume":"95","author":"Dalton","year":"2006","journal-title":"Br. J. Cancer Suppl."},{"issue":"6","key":"10.1016\/j.phrs.2020.105295_bib0075","first-page":"585","article-title":"Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients","volume":"75","author":"Ravn","year":"2010","journal-title":"Acta Psychiat. Scand."},{"issue":"4","key":"10.1016\/j.phrs.2020.105295_bib0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: An antipsychotic agent suppresses metastatic tumor growth in triple negative breast cancer by inhibiting integrin signaling axis","volume":"76","author":"Ranjan","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.105295_bib0085","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.18632\/oncotarget.23192","article-title":"Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action","volume":"9","author":"Mi","year":"2018","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.phrs.2020.105295_bib0090","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-18-0056","article-title":"Osteocyte-driven downregulation of snail restrains effects of Drd2 inhibitors on mammary tumor cells","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2020.105295_bib0095","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41419-018-1046-3","article-title":"The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis","volume":"9","author":"Feng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R","volume":"16","author":"Kang","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1029","key":"10.1016\/j.phrs.2020.105295_bib0105","first-page":"1","article-title":"Antipsychotic drug trifluoperazine suppresses colorectal Cancer by inducing G0\/G1 arrest and apoptosis","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105295_bib0110","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/2211-5463.12960","article-title":"Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma","volume":"10","author":"Li","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","article-title":"To be or not to be? How selective autophagy and cell death govern cell fate","volume":"157","author":"Green","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-017-0436-9","article-title":"Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment","volume":"10","author":"Yoshida","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"33","key":"10.1016\/j.phrs.2020.105295_bib0125","doi-asserted-by":"crossref","first-page":"13599","DOI":"10.1074\/jbc.M117.782276","article-title":"Accumulation of autophagosomes confers cytotoxicity","volume":"292","author":"Button","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"Pt 10","key":"10.1016\/j.phrs.2020.105295_bib0130","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1242\/jcs.093575","article-title":"Die another way--non-apoptotic mechanisms of cell death","volume":"127","author":"Tait","year":"2014","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.phrs.2020.105295_bib0135","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-20-1675","article-title":"Chloroquine sensitizes GNAQ\/11-mutated melanoma to MEK1\/2 inhibition","author":"Truong","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.phrs.2020.105295_bib0140","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.7150\/thno.42291","article-title":"Multifunctional N-P-doped carbon dots for regulation of apoptosis and autophagy in B16F10 melanoma cancer cells and in vitro imaging applications","volume":"10","author":"Bajpai","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0145","first-page":"459","article-title":"Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases","volume":"9","author":"Xu","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2020.105295_bib0150","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41418-019-0422-6","article-title":"LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice","volume":"27","author":"Tan","year":"2020","journal-title":"Cell Death Differ."},{"issue":"18","key":"10.1016\/j.phrs.2020.105295_bib0155","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1158\/0008-5472.CAN-12-1803","article-title":"SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"issue":"117","key":"10.1016\/j.phrs.2020.105295_bib0160","doi-asserted-by":"crossref","DOI":"10.3791\/54657","article-title":"Advanced animal model of colorectal metastasis in liver: imaging techniques and properties of metastatic clones","author":"Oshima","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"67","key":"10.1016\/j.phrs.2020.105295_bib0165","first-page":"e4260","article-title":"Models of bone metastasis","author":"Campbell","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.phrs.2020.105295_bib0170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phrs.2020.105295_bib0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"issue":"21","key":"10.1016\/j.phrs.2020.105295_bib0180","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.18632\/oncotarget.26725","article-title":"AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer","volume":"10","author":"Goyette","year":"2019","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0185","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-017-0588-z","article-title":"Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.105295_bib0195","first-page":"545","article-title":"Trifluoperazine prolongs the survival of experimental brain metastases by STAT3-dependent lysosomal membrane permeabilization","volume":"10","author":"Zhang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.phrs.2020.105295_bib0200","article-title":"The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review","author":"van Opijnen","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2020.105295_bib0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"Gupta","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2020.105295_bib0210","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1172\/JCI62058","article-title":"Targeting the FOXO1\/KLF6 axis regulates EGFR signaling and treatment response","volume":"122","author":"Sangodkar","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"19","key":"10.1016\/j.phrs.2020.105295_bib0215","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1158\/1078-0432.CCR-13-0259","article-title":"The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma","volume":"19","author":"Sheppard","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Proliferat."},{"issue":"29","key":"10.1016\/j.phrs.2020.105295_bib0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"1-2","key":"10.1016\/j.phrs.2020.105295_bib0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mito.2006.11.026","article-title":"Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage","volume":"7","author":"Indo","year":"2007","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-018-0728-0","article-title":"The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance","volume":"37","author":"Weng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.phrs.2020.105295_bib0240","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI26321","article-title":"Pharmacological manipulation of cell death: clinical applications in sight?","volume":"115","author":"Green","year":"2005","journal-title":"J. Clin.Invest."},{"issue":"4","key":"10.1016\/j.phrs.2020.105295_bib0245","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008714","article-title":"Mechanisms of action of Bcl-2 family proteins","volume":"5","author":"Shamas-Din","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"53","key":"10.1016\/j.phrs.2020.105295_bib0250","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phrs.2020.105295_bib0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41419-017-0018-3","article-title":"Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2020.105295_bib0260","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41419-019-1844-2","article-title":"MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1\/AMPK signaling","volume":"10","author":"Jin","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.105295_bib0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12272-020-01239-w","article-title":"Role of autophagy in regulation of cancer cell death\/apoptosis during anti-cancer therapy: focus on autophagy flux blockade","volume":"43","author":"Tilija Pun","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.phrs.2020.105295_bib0270","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41419-020-2440-1","article-title":"Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression","volume":"11","author":"Fu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2 Suppl","key":"10.1016\/j.phrs.2020.105295_bib0275","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0280","article-title":"Trifluoperazine versus placebo for schizophrenia","volume":"2014","author":"Koch","year":"2014","journal-title":"Cochrane DB Syst Rev"},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0285","article-title":"Trifluoperazine for schizophrenia","volume":"2004","author":"Marques","year":"2004","journal-title":"Cochrane DB Syst Rev"},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2125.1983.tb01515.x","article-title":"Kinetics of oral trifluoperazine disposition in man","volume":"15","author":"Midha","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105295_bib0295","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.119.086744","article-title":"Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"120","key":"10.1016\/j.phrs.2020.105295_bib0300","doi-asserted-by":"crossref","DOI":"10.3791\/55085","article-title":"Intracarotid cancer cell injection to produce mouse models of brain metastasis","author":"Zhang","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0305","first-page":"49","article-title":"Brain metastasis: unique challenges and open opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"BBA-Rev Cancer"},{"issue":"7576","key":"10.1016\/j.phrs.2020.105295_bib0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"118","key":"10.1016\/j.phrs.2020.105295_bib0315","doi-asserted-by":"crossref","DOI":"10.3791\/54903","article-title":"A portal vein injection model to study liver metastasis of breast cancer","author":"Goddard","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"91","key":"10.1016\/j.phrs.2020.105295_bib0320","doi-asserted-by":"crossref","DOI":"10.3791\/51677-v","article-title":"A preclinical murine model of hepatic metastases","author":"Soares","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"115","key":"10.1016\/j.phrs.2020.105295_bib0325","doi-asserted-by":"crossref","DOI":"10.3791\/53982","article-title":"Intra-iliac artery injection for efficient and selective modeling of microscopic bone metastasis","author":"Yu","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.phrs.2020.105295_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05366-3","article-title":"A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries","volume":"9","author":"Kuchimaru","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2020.105295_bib0335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/mol.114.096941","article-title":"Repurposing the antipsychotic trifluoperazine as an antimetastasis agent","volume":"87","author":"Ashleigh","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105295_bib0340","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-019-01762-4","article-title":"Repositioning of the antipsychotic drug TFP for sepsis treatment","volume":"97","author":"Park","year":"2019","journal-title":"J. Mol. Med."},{"issue":"28","key":"10.1016\/j.phrs.2020.105295_bib0345","doi-asserted-by":"crossref","first-page":"25308","DOI":"10.18632\/oncotarget.4490","article-title":"Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer","volume":"6","author":"Yuan","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.phrs.2020.105295_bib0350","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1002\/jcb.26848","article-title":"Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells","volume":"119","author":"Fancy","year":"2018","journal-title":"J. Cell. Biochem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:21:55Z","timestamp":1760912515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820316030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":70,"alternative-id":["S1043661820316030"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105295","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105295"}}